Latest stories on JBIO
Jade Biosciences Launches Major Underwritten Equity Offering
TipRanks58 · neutralproduct/pr
Jade Biosciences prices $150M public offering of common stock at $15/share
Seeking Alpha58 · neutralgeneral
Jade Biosciences Announces Pricing of Public Offering of Common Stock | JBIO Stock News
StockTitan58 · neutralproduct/pr
Jade Biosciences plans public offering, pre-funded warrants
Seeking Alpha47 · neutralgeneral
Jade Biosciences Announces Proposed Underwritten Public Offering | JBIO Stock News
StockTitan53 · neutralgeneral
Jade Biosciences Reports Positive Phase 1 JADE101 Results
TipRanks67 · bullishproduct/pr
Jade Biosciences to Host Conference Call and Webcast on June 1, 2026, at 8:00 a.m. ET to Discuss Interim Phase 1 Healthy Volunteer Results for JADE101, a Novel, Potentially Best-in-Class Anti-APRIL Monoclonal Antibody in Development for IgA Nephropathy | JBIO Stock News
StockTitan53 · neutralproduct/pr